Kinnate Biopharma shares owned by UBS Group
Quarter-by-quarter ownership of Kinnate Biopharma shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Kinnate Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Kinnate Biopharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Kinnate Biopharma by UBS Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $2.2k | 818 | 2.66 |
2023-12-31 | $12k | 5.1k | 2.37 |
2021-09-30 | $17k | 730 | 23.29 |
2021-06-30 | $6.0k | 252 | 23.81 |
2021-03-31 | $25k | 788 | 31.73 |
2020-12-31 | $1.6M | 40k | 39.77 |
Top funds holding Kinnate Biopharma
View all funds holding Kinnate Biopharma